Comparison of surgery rates in biologic-naïve patients with Crohn’s disease treated with vedolizumab or ustekinumab: findings from SOJOURN

Table 2 Proportion of patients who underwent each Crohn’s disease-related surgery type

CD-related surgery type, n (%)	Total N = 1,122	Vedolizumab N = 578	Ustekinumab N = 544	p value
Abscess drainage	22 (1.96)	13 (2.25)	9 (1.65)	0.473
Abscess drainage with fistula repair	4 (0.36)	1 (0.17)	3 (0.55)	0.288
Seton placement	12 (1.07)	4 (0.69)	8 (1.47)	0.205
Fistula repair/stricturoplasty	37 (3.30)	15 (2.60)	22 (4.04)	0.174
Excision/resection: overall	54 (4.81)	22 (3.81)	32 (5.88)	0.104
Excision/resection of the small or large intestine^a	1 (0.09)	0 (0.00)	1 (0.18)	0.302
Excision/resection of the large intestine	47 (4.19)	20 (3.46)	27 (4.96)	0.209
Excision/resection of the small intestine	33 (2.94)	10 (1.73)	23 (4.23)	0.013

A surgery event was attributed to a category if it contained at least one of the procedure codes corresponding to the surgery category type
CD Crohn’s disease
^aThe surgery procedure code did not specify the location

ISSN: 1471-230X